Zolpidem in the treatment of insomnia: Mechanism of action, risk of dependence, and withdrawal syndrome
Pharmacotherapy in Psychiatry and Neurology · 2026
DOI: 10.17219/fpn/225353 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacotherapy in Psychiatry and Neurology, 2026. Verfasst von Julia Sławińska und 9 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Themen: Schlaf
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Sławińska, J., Mielnicka, W., Mikołajczyk, J., Hawajski, A., Nowak, J., Mieruszyńska, S., Szeidl, O., Kołodziejska, M., Lewandowski, M., & Cupiał, A. (2026). Zolpidem in the treatment of insomnia: Mechanism of action, risk of dependence, and withdrawal syndrome. Pharmacotherapy in Psychiatry and Neurology. https://doi.org/10.17219/fpn/225353
Vancouver
Sławińska J, Mielnicka W, Mikołajczyk J, Hawajski A, Nowak J, Mieruszyńska S, et al. Zolpidem in the treatment of insomnia: Mechanism of action, risk of dependence, and withdrawal syndrome. Pharmacotherapy in Psychiatry and Neurology. 2026. doi:10.17219/fpn/225353
BibTeX
@article{Sawiska2026,
author = {Sławińska, Julia and Mielnicka, Weronika and Mikołajczyk, Jagoda and Hawajski, Artur and Nowak, Jan and Mieruszyńska, Stella and Szeidl, Olga and Kołodziejska, Maja and Lewandowski, Marcin and Cupiał, Anna},
title = {Zolpidem in the treatment of insomnia: Mechanism of action, risk of dependence, and withdrawal syndrome},
journal = {Pharmacotherapy in Psychiatry and Neurology},
year = {2026},
doi = {10.17219/fpn/225353}
}
EUVIMED